Shares of Diaceutics PLC (LON:DXRX – Get Free Report) fell 7.1% on Tuesday . The company traded as low as GBX 153.35 and last traded at GBX 153.35. 216,605 shares were traded during mid-day trading, an increase of 41% from the average session volume of 153,098 shares. The stock had previously closed at GBX 165.
Diaceutics Stock Performance
The firm’s fifty day moving average price is GBX 161.20 and its 200-day moving average price is GBX 154.52. The company has a current ratio of 3.96, a quick ratio of 9.92 and a debt-to-equity ratio of 3.05. The firm has a market cap of £127.72 million, a price-to-earnings ratio of -83.84 and a beta of 0.92.
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.
Read More
- Five stocks we like better than Diaceutics
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for Diaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diaceutics and related companies with MarketBeat.com's FREE daily email newsletter.
